Press

February 13, 2020

Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin

  • Targeted colonic delivery shown

  • Drug well-tolerated

WAKEFIELD, MA – February 13, 2020 (GLOBE NEWSWIRE) Innovatio...

June 6, 2019


BEVERLY, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, has signed an agreement with BDD Pharma, an award-winning drug delivery company specializing in modified and controll...

April 2, 2019

Aspirin is widely used to relieve acute pain and reduce fever and inflammation. New 500 mg and 1000 mg aspirin rapid disintegrating tablets with small active ingredient particle size and sodium carbonate excipient were developed to replace regular 500 mg aspirin tablet...

Please reload

Featured Posts

BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology

May 30, 2018

1/2
Please reload

Recent Posts

November 16, 2016

January 29, 2016

December 3, 2015

Please reload

Archive
Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square